ReviewHeart failure reviews2012
Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment.
Review in Heart failure reviews, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 33 citations in OpenAlex.
- Etiology-Related Differences in Left Ventricular Remodeling and Left Atrial Function in Patients with Heart Failure and Reduced Ejection Fraction Referred for ICD/CRT Implantation.Journal of clinical medicine · 2026Article
- Article
- Risk factors and outcomes of renal insufficiency after colectomy for diverticulitis.Techniques in coloproctology · 2024Article
- Comparison of renal impairment post-myocardial infarction with reduced and preserved left ventricular function in rats with normal renal function.Renal failure · 2020Article
- Use of cardiovascular drugs and risk of incident heart failure in patients with atrial fibrillation.Journal of clinical hypertension (Greenwich, Conn.) · 2020Article
- New challenges of geriatric cardiology: from clinical to preclinical research.Journal of geriatric cardiology : JGC · 2017Article
- Urinary cadmium levels predict mortality of patients with acute heart failure.Therapeutics and clinical risk management · 2017Article
- Nutrition and Cardiovascular Disease: Finding the Perfect Recipe for Cardiovascular Health.Nutrients · 2016Review
- Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin.Clinical research in cardiology : official journal of the German Cardiac Society · 2015Review
- New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy.Journal of cardiovascular translational research · 2013Review
- Current strategies for preventing renal dysfunction in patients with heart failure: a heart failure stage approach.Clinics (Sao Paulo, Brazil) · 2013Review
- Angiotensin II receptor blocker attenuates intrarenal renin-angiotensin-system and podocyte injury in rats with myocardial infarction.PloS one · 2013Article
- Cardiorenal biomarkers in acute heart failure.Journal of geriatric cardiology : JGC · 2012Article
- The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?Heart failure reviews · 2012Review
- The puzzle of kidney dysfunction in heart failure: an introduction.Heart failure reviews · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal dysfunction is often present and/or worsens in patients with heart failure and this is associated with increased costs of care, complications and mortality. The cardiorenal syndrome can be defined as the presence or development of renal dysfunction in patients with heart failure. Its mechanisms are likely related to low cardiac output, increased venous congestion and renal venous pressure, neurohormonal and inflammatory activation and local changes, such as adenosine release. Many drugs, including loop diuretics, may contribute to worsening renal function through the activation of some of these mechanisms. Renal damage is conventionally defined by the increase in creatinine and blood urea nitrogen blood levels. However, these changes may be not related with renal injury or prognosis. New biomarkers of renal injury seem promising but still need to be validated. Thus, despite the epidemiological evidence, we are still lacking of satisfactory tools to assess renal injury and function and its prognostic significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.